Jefferies Financial Group Forecasts Strong Price Appreciation for Cardinal Health (NYSE:CAH) Stock

Cardinal Health (NYSE:CAH) had its price objective raised by investment analysts at Jefferies Financial Group from $220.00 to $270.00 in a research report issued on Thursday,MarketScreener reports. The brokerage presently has a “buy” rating on the stock. Jefferies Financial Group’s target price would indicate a potential upside of 29.63% from the stock’s previous close.

Several other brokerages have also commented on CAH. Mizuho set a $222.00 price objective on shares of Cardinal Health in a report on Monday, January 12th. Robert W. Baird set a $250.00 price target on Cardinal Health in a research report on Wednesday, January 14th. Citigroup raised Cardinal Health from a “neutral” rating to a “buy” rating and raised their price objective for the company from $190.00 to $244.00 in a research report on Friday, January 9th. Barclays started coverage on shares of Cardinal Health in a research note on Monday, December 8th. They issued an “overweight” rating and a $243.00 price target for the company. Finally, Weiss Ratings restated a “buy (b)” rating on shares of Cardinal Health in a report on Wednesday, October 8th. Fourteen investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to data from MarketBeat.com, Cardinal Health presently has a consensus rating of “Moderate Buy” and a consensus price target of $219.67.

Cardinal Health Stock Performance

CAH opened at $208.29 on Thursday. The stock has a market capitalization of $49.49 billion, a PE ratio of 31.42, a price-to-earnings-growth ratio of 1.40 and a beta of 0.65. The stock’s 50 day moving average price is $205.78 and its 200-day moving average price is $176.18. Cardinal Health has a 52-week low of $120.72 and a 52-week high of $215.48.

Cardinal Health (NYSE:CAH) last released its quarterly earnings results on Thursday, October 30th. The company reported $2.55 earnings per share for the quarter, beating the consensus estimate of $2.22 by $0.33. Cardinal Health had a net margin of 0.68% and a negative return on equity of 84.37%. The business had revenue of $64.01 billion for the quarter, compared to analysts’ expectations of $59.41 billion. During the same quarter in the previous year, the business posted $1.88 earnings per share. The firm’s revenue for the quarter was up 22.4% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. Research analysts forecast that Cardinal Health will post 7.95 EPS for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Farther Finance Advisors LLC raised its stake in Cardinal Health by 25.8% during the 4th quarter. Farther Finance Advisors LLC now owns 14,487 shares of the company’s stock valued at $2,977,000 after buying an additional 2,973 shares during the last quarter. Sage Mountain Advisors LLC boosted its holdings in shares of Cardinal Health by 11.0% in the fourth quarter. Sage Mountain Advisors LLC now owns 2,991 shares of the company’s stock worth $615,000 after buying an additional 296 shares during the last quarter. Freestone Capital Holdings LLC increased its holdings in Cardinal Health by 3.7% during the fourth quarter. Freestone Capital Holdings LLC now owns 59,049 shares of the company’s stock valued at $12,135,000 after buying an additional 2,092 shares during the last quarter. Cura Wealth Advisors LLC bought a new position in Cardinal Health in the fourth quarter worth approximately $227,000. Finally, Assetmark Inc. boosted its stake in shares of Cardinal Health by 14.4% during the 4th quarter. Assetmark Inc. now owns 78,139 shares of the company’s stock worth $16,058,000 after acquiring an additional 9,823 shares during the last quarter. Institutional investors own 87.17% of the company’s stock.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.